Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2025 Earnings Call Transcript October 30, 2025
Travere Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.31.
Operator: Good afternoon, and welcome to the Travere Therapeutics’ Third Quarter 2025 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice President, Corporate Communications and Investor Relations. Please...
